Published in J Clin Med on December 22, 2014
Characteristics of adipose tissue macrophages and macrophage-derived insulin-like growth factor-1 in virus-induced obesity. Int J Obes (Lond) (2015) 0.85
The Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity. Biochem Insights (2017) 0.75
Developments in our understanding of the effects of growth hormone on white adipose tissue from mice: implications to the clinic. Expert Rev Endocrinol Metab (2016) 0.75
Obesity and Cancer Metabolism: A Perspective on Interacting Tumor-Intrinsic and Extrinsic Factors. Front Oncol (2017) 0.75
A regulatory mutation in IGF2 causes a major QTL effect on muscle growth in the pig. Nature (2003) 5.41
Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol (2007) 3.83
Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab (2000) 2.27
Minireview: IGF, Insulin, and Cancer. Endocrinology (2011) 2.16
Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet (2002) 2.12
Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab (2010) 1.85
Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) (1989) 1.83
Hormone families: pancreatic hormones and homologous growth factors. Nature (1980) 1.71
IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis. Trends Endocrinol Metab (2009) 1.65
Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab (2007) 1.64
General and abdominal obesity parameters and their combination in relation to mortality: a systematic review and meta-regression analysis. Eur J Clin Nutr (2013) 1.54
Estrogen regulation of growth hormone action. Endocr Rev (2004) 1.54
Reproduction, fat metabolism, and life span: what is the connection? Cell Metab (2013) 1.51
Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocr Relat Cancer (2012) 1.48
Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Mol Endocrinol (2004) 1.44
Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive. Endocr Rev (2013) 1.39
Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer. Arterioscler Thromb Vasc Biol (2012) 1.23
Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism. FASEB J (2008) 1.23
Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab (1995) 1.23
Insulin resistance and cancer: the role of insulin and IGFs. Endocr Relat Cancer (2013) 1.21
Free insulin-like growth factors in human obesity. Metabolism (1995) 1.20
Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample. Eur J Endocrinol (2009) 1.18
The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations. Nat Rev Endocrinol (2013) 1.09
Insulin-like growth factor axis and risk of type 2 diabetes in women. Diabetes (2012) 1.08
Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3. Am J Physiol Endocrinol Metab (2009) 1.06
Characterising metabolically healthy obesity in weight-discordant monozygotic twins. Diabetologia (2013) 1.06
GH/IGF-I regulation in obesity--mechanisms and practical consequences in children and adults. Horm Res Paediatr (2010) 1.04
Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin North Am (2012) 1.02
Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis. Clin Endocrinol (Oxf) (2007) 1.02
Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. Diabetologia (2008) 1.02
Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity. J Clin Endocrinol Metab (2008) 1.01
Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects. Eur J Endocrinol (2006) 1.00
Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity. J Clin Endocrinol Metab (2013) 0.96
Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study. Diabetes Metab (2009) 0.96
Three new players in energy regulation: preptin, adropin and irisin. Peptides (2014) 0.95
Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH. Eur J Endocrinol (2001) 0.94
Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden). Cancer Causes Control (2002) 0.94
Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab (2013) 0.93
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels. Clin Endocrinol (Oxf) (2012) 0.92
The insulin-like growth factors in adipogenesis and obesity. Endocrinol Metab Clin North Am (2012) 0.91
Low circulating IGF-II concentrations predict weight gain and obesity in humans. Diabetes (2003) 0.91
Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females. J Transl Med (2011) 0.91
Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3. PLoS One (2012) 0.91
Rapid suppression of growth hormone concentration by overeating: potential mediation by hyperinsulinemia. J Clin Endocrinol Metab (2011) 0.90
IGF-binding protein-1 inhibits IGF effects on adipocyte function: implications for insulin-like actions at the adipocyte. J Endocrinol (2002) 0.89
IGFBP-3 inhibits cytokine-induced insulin resistance and early manifestations of atherosclerosis. PLoS One (2013) 0.88
The IGF-I system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat. Growth Horm IGF Res (2004) 0.87
IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women. Eur J Endocrinol (2010) 0.86
Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes. Growth Horm IGF Res (2010) 0.85
IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy. J Diabetes Complications (2012) 0.84
No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance. Obes Res (2001) 0.84
IGFBP-2 at the interface of growth and metabolism--implications for childhood obesity. Pediatr Endocrinol Rev (2011) 0.83
Insulin and IGF-I inhibit GH synthesis and release in vitro and in vivo by separate mechanisms. Endocrinology (2013) 0.83
Regulation of soluble insulin-like growth factor II/mannose 6-phosphate receptor in human serum: measurement by enzyme-linked immunosorbent assay. J Clin Endocrinol Metab (1999) 0.83
Polymorphisms in IGF-binding protein 1 are associated with impaired renal function in type 2 diabetes. Diabetes (2005) 0.83
Human IGF binding protein-3 overexpression impairs glucose regulation in mice via an inhibition of insulin secretion. Endocrinology (2011) 0.83
IGF2/H19 hypomethylation in a patient with very low birthweight, preocious pubarche and insulin resistance. BMC Med Genet (2012) 0.82
Interactions among pro-inflammatory cytokines, IGF system and thyroid function in pre-pubertal obese subjects. J Biol Regul Homeost Agents (2013) 0.81
Preferential expression of PAPPA in human preadipocytes from omental fat. J Endocrinol (2014) 0.81
Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity. J Clin Endocrinol Metab (2004) 0.80
Insulin-like growth factor-binding protein-1: a role in glucose counterregulation? Mol Cell Endocrinol (1991) 0.80
Implication of insulin receptor A isoform and IRA/IGF-IR hybrid receptors in the aortic vascular smooth muscle cell proliferation: role of TNF-α and IGF-II. Endocrinology (2013) 0.80
Adiponectin, body mass index and hepatic steatosis are independently associated with IGF-I status in obese non-diabetic women. Growth Horm IGF Res (2012) 0.79
Longitudinal association between IGFBP-1 levels and parameters of the metabolic syndrome in obese children before and after weight loss. Int J Pediatr Obes (2011) 0.79
Insulin-like growth factor I and anthropometric parameters in a Danish population. Exp Clin Endocrinol Diabetes (2012) 0.79
Microdialysis of insulin-like growth factor-I in human muscle. Eur J Appl Physiol (2005) 0.79
Insulin stimulates IGFBP-2 expression in 3T3-L1 adipocytes through the PI3K/mTOR pathway. Mol Cell Endocrinol (2012) 0.78
Low insulin-like growth factor-II levels predict weight gain in normal weight subjects with type 2 diabetes. Am J Med (2006) 0.78
Serum concentrations of insulin-like growth factor-I, insulin-like growth factor binding protein-3 and cardiovascular risk factors in adolescents. Ann Clin Biochem (2011) 0.78
Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity. Clin Endocrinol (Oxf) (1990) 0.78
Posttranslational modifications of the insulin-like growth factor-binding protein 3 in patients with type 2 diabetes mellitus assessed by affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.77
Specific cleavage of insulin-like growth factor-binding protein-1 by a novel protease activity. Cell Mol Life Sci (2006) 0.77
Interactions of the IGF System with Diabetes and its Vascular Complications. Exp Clin Endocrinol Diabetes (2013) 0.77
The growth hormone-insulin-like growth factor axis in adult patients with Prader Willi syndrome. Growth Horm IGF Res (2003) 0.77
Delta insulin-like growth factor binding protein-1 (ΔIGFBP-1): a marker of hepatic insulin resistance? Ann Clin Biochem (2013) 0.77
Association between the pattern of IGFBP-1 alteration and the glucose/insulin metabolic control. Exp Clin Endocrinol Diabetes (2010) 0.76
The obesity of patients with Laron Syndrome is not associated with excessive nutritional intake. Obes Res Clin Pract (2009) 0.76
The production and regulation of IGF and IGFBPs in human adipose tissue cultures. Growth Horm IGF Res (2012) 0.76
Effect of Ghrelin on Hepatic IGF-Binding Protein-1 Production. ISRN Obes (2013) 0.76
Beyond waist circumference in an adult male population of Southern Italy: Is there any role for subscapular skinfold thickness in the relationship between insulin-like growth factor-I system and metabolic parameters? J Endocrinol Invest (2012) 0.75